Qube Research & Technologies (QRT)
DTIL icon

Qube Research & Technologies (QRT)’s Precision BioSciences DTIL Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-19,443
Closed -$107K – 3608
2026
Q1 		$107K Buy
+19,443
New +$89.7K ﹤0.01% 3059
2024
Q3 		– Sell
-8
Closed -$78 – 3494
2024
Q2 		$78 Buy
8
+3
+60% +$35 ﹤0.01% 3452
2024
Q1 		$68 Sell
5
-4
-44% -$49 ﹤0.01% 4201
2023
Q4 		$93 Hold
9
– – ﹤0.01% 4028
2023
Q3 		$87 Buy
+9
New +$138 ﹤0.01% 3774
2023
Q2 		– Sell
-438
Closed -$9.9K – 2532
2023
Q1 		$9.9K Sell
438
-1,448
-77% -$47.7K ﹤0.01% 2364
2022
Q4 		$67.3K Buy
1,886
+680
+56% +$26.9K ﹤0.01% 2095
2022
Q3 		$47K Sell
1,206
-1,210
-50% -$57.5K ﹤0.01% 2149
2022
Q2 		$116K Buy
+2,416
New +$142K ﹤0.01% 1886
2022
Q1 		– Sell
-1,092
Closed -$242K – 2570
2021
Q4 		$242K Buy
+1,092
New +$305K ﹤0.01% 1894

Other funds holding DTIL

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Qube Research & Technologies (QRT)'s DTIL Position: Q2 2026 in Review

Qube Research & Technologies (QRT) sold out of Precision BioSciences (DTIL) in Q2 2026, closing a stake of 19,443 shares — an estimated $107K sold.

Qube Research & Technologies (QRT) first reported a position in DTIL in Q4 2021 and held it in 10 quarters. The position peaked at $242K in Q4 2021. 95 funds tracked by Wall St. Rank hold DTIL as of Q2 2026.

  • Qube Research & Technologies (QRT) reported no remaining Precision BioSciences position as of Q2 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 19,443 Precision BioSciences shares in Q2 2026, an estimated $107K.
  • Qube Research & Technologies (QRT) first reported a position in Precision BioSciences in Q4 2021 and held it in 10 quarters.
  • Qube Research & Technologies (QRT)'s Precision BioSciences position peaked at $242K in Q4 2021.
  • 95 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.